As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
At iTeos Therapeutics, a filing with the SEC revealed that on Thursday, Chief Financial Officer Matthew Gall purchased 5,000 shares of ITOS, for a cost of $8.37 each, for a total investment of $41,850. So far Gall is in the green, up about 8.2% on their purchase based on today's trading high of $9.06. iTeos Therapeutics Inc is trading off about 5.4% on the day Monday.
And at Aehr Test Systems, there was insider buying on Wednesday, by Howard T. Slayen who purchased 700 shares at a cost of $40.20 each, for a trade totaling $28,140. Aehr Test Systems is trading off about 1.6% on the day Monday. Investors are able to pick up AEHR even cheaper than Slayen did, with shares trading as low as $37.17 in trading on Monday which is 7.5% below Slayen's purchase price.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.